Open AccessLow-Intensity Therapy in Adults with Burkitt's Lymphoma
Author(s) -
Kieron Dunleavy,
Stefania Pittaluga,
Margaret Shovlin,
Seth M. Steinberg,
Diane E. Cole,
Clíona Grant,
Brigitte C. Widemann,
Louis M. Staudt,
Elaine S. Jaffe,
Richard F. Little,
Wyndham H. Wilson
Publication year - 2013
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1308392
Subject(s) - medicine , lymphoma , burkitt's lymphoma , chemotherapy , oncology , pediatrics
Burkitt's lymphoma is an aggressive B-cell lymphoma that occurs in children and adults and is largely curable with the use of intensive and toxic chemotherapy. Current treatments are less effective and have more severe side effects in adults and patients with immunodeficiency than in children.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom